Vivek Naranbhai

13PUBLICATIONS
130CO-AUTHORS
Proteins and peptidesPredictive and prognostic markersCellular immunologyRespiratory diseasesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 05, 2026
Incidence of Reported Pseudoprogression on 18F-FDG PET/CT in Metastatic Melanoma Patients Undergoing Immune Checkpoint Inhibitor Immunotherapy.

Philip Macilwraith, Mark Shackleton, Andrew Haydon

|Nov 14, 2025
Utility of bronchoalveolar lavage in checkpoint inhibitor pneumonitis evaluation: a narrative review.

Senthuran Shivakumar, Sagun Parakh, Natalia Vukelic

|Nov 29, 2023
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.

Reza Zonozi, Lucy C Walters, Aaron Shulkin

|Jan 09, 2023
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2.

Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai

|Jul 20, 2022
Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner.

Victoria Walker-Sperling, Jean C Digitale, Mathias Viard

Pageof 3